000 01529nam a2200385 4500
001 9345125
005 20150216104315.0
006 000
007 000
008 000
020 _a9780841205888
020 _a0841205884
035 _a(WaSeSS)ssj0000596788
040 _aOUEL
_cDNLM
_dDNLM
_dWaSeSS
060 0 0 _aQU 130
_bI582 1980
210 1 0 _aInorganic chemistry in biology and medicine
245 0 0 _aInorganic chemistry in biology and medicine
_h[electronic resource] /
_cArthur E. Martell, editor.
260 _aWashington, D.C. :
_bAmerican Chemical Society,
_c1980.
300 _aviii, 436. p ;
_bill. ;
_c26 cm
490 1 _aACS symposium series ;
_v140
500 _a"Based on a symposium sponsored by the Division of Inorganic Chemistry at the 178th Meeting of the American Chemical Society, Washington, D.C. September 10-11. 1979."
506 _aLicense restrictions may limit access.
650 2 _aChelating Agents
_xtherapeutic use
650 2 _aMetals
_xmetabolism
650 2 _aMetals
_xtherapeutic use
655 2 _aCongresses
700 1 _aMartell, Arthur E.
710 2 _aAmerican Chemical Society.
_bDivision of Inorganic Chemistry.
710 2 _aAmerican Chemical Society.
_bMeeting
_n(178th :
_d1979 :
_cWashington, D.C.)
773 0 _tACS Symposium Series
830 0 _aACS symposium series ;
_v140.
856 4 0 _uhttp://www.columbia.edu/cgi-bin/cul/resolve?clio9345125
_zFull text available from ACS Symposium Series
910 _aNational Library of Medicine record
942 _2lcc
_cLL
999 _c2145
_d2145